Replies to post #110150 on Biotech Values

[tekcor_atnm]

I haven't seen Teva say this before:
The lawsuit won't keep Teva from taking a risk and proceeding with the marketing of its generic version of Lovenox

And from the highlighted paragraph, I haven't seen Marth say the following specifically:
"...and does not copy the Momenta method."